These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Zheng ZH; Li XY; Ding J; Jia JF; Zhu P Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486 [TBL] [Abstract][Full Text] [Related]
3. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Poncelet AJ; Vercruysse J; Saliez A; Gianello P Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713 [TBL] [Abstract][Full Text] [Related]
4. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Oh W; Kim DS; Yang YS; Lee JK Cell Immunol; 2008 Feb; 251(2):116-23. PubMed ID: 18495100 [TBL] [Abstract][Full Text] [Related]
5. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164 [TBL] [Abstract][Full Text] [Related]
6. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation. Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586 [TBL] [Abstract][Full Text] [Related]
8. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390 [TBL] [Abstract][Full Text] [Related]
9. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1. Usui Y; Okunuki Y; Hattori T; Takeuchi M; Kezuka T; Goto H; Usui M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4607-13. PubMed ID: 17003458 [TBL] [Abstract][Full Text] [Related]
10. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro. Comoli P; Montagna D; Moretta A; Zecca M; Locatelli F; Maccario R J Immunol; 1995 Dec; 155(12):5506-11. PubMed ID: 7499831 [TBL] [Abstract][Full Text] [Related]
11. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Yoo KH; Jang IK; Lee MW; Kim HE; Yang MS; Eom Y; Lee JE; Kim YJ; Yang SK; Jung HL; Sung KW; Kim CW; Koo HH Cell Immunol; 2009; 259(2):150-6. PubMed ID: 19608159 [TBL] [Abstract][Full Text] [Related]
12. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15. Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856 [TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Chen K; Wang D; Du WT; Han ZB; Ren H; Chi Y; Yang SG; Zhu D; Bayard F; Han ZC Clin Immunol; 2010 Jun; 135(3):448-58. PubMed ID: 20207200 [TBL] [Abstract][Full Text] [Related]
14. The immunobiological development of human bone marrow mesenchymal stem cells in the course of neuronal differentiation. Liu CT; Yang YJ; Yin F; Wang X; Yu XH; Wang QH; Wang XL; Xie M Cell Immunol; 2006 Nov; 244(1):19-32. PubMed ID: 17448455 [TBL] [Abstract][Full Text] [Related]
15. Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes. Corrigall VM; Solau-Gervais E; Panayi GS Arthritis Rheum; 2000 Jul; 43(7):1606-15. PubMed ID: 10902766 [TBL] [Abstract][Full Text] [Related]
16. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Comoli P; Ginevri F; Maccario R; Avanzini MA; Marconi M; Groff A; Cometa A; Cioni M; Porretti L; Barberi W; Frassoni F; Locatelli F Nephrol Dial Transplant; 2008 Apr; 23(4):1196-202. PubMed ID: 18029377 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Rasmusson I; Ringdén O; Sundberg B; Le Blanc K Exp Cell Res; 2005 Apr; 305(1):33-41. PubMed ID: 15777785 [TBL] [Abstract][Full Text] [Related]
18. Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules. Chen X; McClurg A; Zhou GQ; McCaigue M; Armstrong MA; Li G Stem Cells; 2007 Feb; 25(2):364-70. PubMed ID: 17068184 [TBL] [Abstract][Full Text] [Related]
19. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Groh ME; Maitra B; Szekely E; Koç ON Exp Hematol; 2005 Aug; 33(8):928-34. PubMed ID: 16038786 [TBL] [Abstract][Full Text] [Related]
20. MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-gamma challenge. Chan WK; Lau AS; Li JC; Law HK; Lau YL; Chan GC Exp Hematol; 2008 Nov; 36(11):1545-55. PubMed ID: 18715686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]